Related Experiment Videos
Digitalis 'receptors' during chronic digoxin treatment
Summary
Digoxin treatment in patients leads to an increase in digoxin receptors in red blood cells. This adaptation helps maintain normal ion balance during long-term cardiac glycoside therapy.
Area of Science:
- Pharmacology
- Cellular Biology
- Biochemistry
Background:
- Cardiac glycosides like digoxin are used to treat heart conditions.
- The sodium-potassium pump (Na+-K+-ATPase) is a key target for digoxin.
- Understanding cellular adaptation to chronic digoxin use is crucial for patient management.
Purpose of the Study:
- To investigate the effect of long-term digoxin treatment on Mg-dependent [Na+-K+]-ATPase.
- To assess cellular adaptations, including receptor synthesis, in response to digoxin.
Main Methods:
- Compared intracellular ions (Na+-K+), 86Rb uptake, and digoxin binding sites in digoxin-treated patients versus controls.
- Conducted a longitudinal study of 32 patients over 1 year.
Main Results:
- Patients on long-term digoxin showed an overcompensatory synthesis of new digoxin receptors in erythrocytes.
- This receptor synthesis appears to re-establish normal intraerythrocytic ionic equilibrium.
- Erythrocyte receptor synthesis completion occurs within approximately 4 months of starting digoxin.
Conclusions:
- Erythrocytes adapt to chronic therapeutic digoxin doses by increasing digoxin receptors.
- This mechanism aids in maintaining intracellular ionic homeostasis.
- The adaptation process is time-dependent, completing within months of treatment initiation.